Psoriasis With Arthropathy — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for psoriasis with arthropathy. 56 active patents protecting 4 drugs from 2+ originators. First major cliff: 2032. Daily refresh.

4
Approved drugs
56
Active US patents
57/100
Avg vulnerability
$2.1B
Annual revenue covered

Originators in Psoriasis With Arthropathy

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Schering) 33 patents Amgen 23 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating psoriasis with arthropathy. Each bar = one year. Y-axis scaled to peak year (20 patents).

5
27
9
28
2
30
5
32
4
33
20
34
1
36
3
37
1
39
1
41

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Otezla
APREMILAST
 Amgen 23 41 $2.1B 2028-02-16
Decadron
dexamethasone
 Generic (originally Merck) 15 46 — 2027-12-19
Cortef
hydrocortisone
 Generic (originally Merck/Upjohn) 14 64 — 2032-11-19
Deltasone
prednisone
 Generic (originally Schering) 4 76 — 2027-08-03

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8168218 Deltasone method of use 80 2028-01-07
9504699 Deltasone method of use 75 2027-08-03
9504699 Deltasone method of use 75 2027-08-03
9504699 Deltasone method of use 75 2027-08-03
12133914 Cortef method of use 75 2043-02-23
11904046 Cortef method of use 75 2043-02-23
8101582 Decadron method of use 63 2027-12-19
7795316 Decadron method of use 63 2028-08-03
9717740 Cortef method of use 62 2032-11-19
9717740 Cortef method of use 62 2032-11-19

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
7427638 Otezla composition of matter 5 2028-02-16
7427638 Otezla composition of matter 5 2028-02-16
7427638 Otezla composition of matter 5 2028-02-16
7427638 Otezla composition of matter 13 2028-02-16
10537585 Decadron formulation 25 2037-12-18
10159683 Decadron formulation 25 2034-05-23
10799642 Decadron formulation 31 2032-05-11
8409606 Decadron formulation 31 2030-05-14
11969409 Otezla formulation 38 2042-05-27
8450287 Decadron formulation 38 2027-12-19

Related